bioAffinity Technologies regains Nasdaq compliance after bid-price recovery
bioAffinity Technologies said it regained Nasdaq minimum $1.00 bid-price compliance and will remain listed on the Nasdaq Capital Market.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.